| PDF (505kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-269404
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.26940
Alternative Links zum Volltext:Pubmed
Zusammenfassung
The single-dose pharmacokinetics of recombinant human erythropoietin (rHuEPO) given SC was investigated in 20 patients aged 7-20 years at different stages of chronic renal failure. In a pilot study we confirmed the lower bioavailability of the drug in 2 children when given SC compared with the IV route (24% and 43%, respectively). Following administration of 4,000 units/m2, rHuEPO SC effective ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Downloadstatistik